WallStSmart
LMAT

LeMaitre Vascular Inc

NASDAQ: LMAT · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$107.27
-4.57% today

Updated 2026-04-29

Market cap
$2.45B
P/E ratio
42.57
P/S ratio
9.82x
EPS (TTM)
$2.52
Dividend yield
0.71%
52W range
$77 – $118
Volume
0.2M

LeMaitre Vascular Inc (LMAT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+3.5%
Last 4 quarters
Revenue YoY growth
+15.7%
Most recent quarter
EPS YoY growth
+38.8%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+8.2%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+25.3%
2026-02-25
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-25$0.68+3.0%$90.75$113.69+25.3%
2025-11-06$0.62+8.8%$86.27$86.82+0.6%
2025-07-30$0.60+5.9%$82.44$81.24-1.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.66$0.68+3.0%$64.45M+15.7%
2025-09-30$0.57$0.62+8.8%$61.05M+11.4%
2025-06-30$0.57$0.60+5.9%$64.23M+15.0%
2025-03-31$0.50$0.48-3.6%$59.87M+12.0%
2024-12-31$0.49$0.49+0.0%$55.72M+14.0%
2024-09-30$0.44$0.49+11.4%$54.82M+15.6%
2024-06-30$0.47$0.52+10.6%$55.85M+11.4%
2024-03-31$0.39$0.44+12.8%$53.48M
2023-12-31$0.36$0.38+5.6%$48.88M
2023-09-30$0.30$0.33+10.0%$47.41M
2023-06-30$0.32$0.36+12.5%$50.12M

Frequently asked questions

Has LeMaitre Vascular Inc beaten earnings estimates?
LeMaitre Vascular Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +3.5% over the last 4 quarters.
How does LMAT stock react to earnings?
LMAT stock has moved an average of +8.2% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is LeMaitre Vascular Inc's revenue growth rate?
LeMaitre Vascular Inc reported year-over-year revenue growth of +15.7% in its most recent quarter, with EPS growing +38.8% year-over-year.